The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
SOAR Technology Acquisition Corp. (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted company on January 29, 2021. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
one or more businesses or entities (a “Business Combination”).
The Company is not limited to a particular industry
or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such,
the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of September 30, 2022, the Company had not
commenced any operations. All activity for the period from January 29, 2021 (inception) through September 30, 2022 relates to the
Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent
to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues
until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest
income from the proceeds derived from the Initial Public Offering.
The Registration Statement on Form S-1, as amended
(File No. 333-253273) (the “Registration Statement”) for the Company’s Initial Public Offering was declared effective
on September 15, 2021. On September 20, 2021, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units”
and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which
includes the full exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units at $10.00 per Unit,
generating gross proceeds of $230,000,000, which is described in Note 3.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 9,666,667 warrants (the “Private Placement Warrants”) at a price of $1.50
per Private Placement Warrant in a private placement to SOAR Technology Sponsor, LP (the “Sponsor”), generating gross proceeds
of $14,500,000, which is described in Note 4.
Transaction costs amounted to $13,412,940, consisting
of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $762,940 of other offering costs.
Following the closing of the Initial Public Offering
on September 20, 2021, an amount of $236,900,000 ($10.30 per Unit) from the net proceeds of the sale of the Units in the Initial
Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) which was
invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as
amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds
itself out as a money market fund meeting the conditions of Rule 2a-7of the Investment Company Act, as determined by the Company, until
the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account to the
Company’s shareholders, as described below.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The stock
exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market
value equal to at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting
commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the
post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under
the Investment Company Act. There is no assurance that the Company will be able to successfully complete a Business Combination.
The Company will provide the holders of the Public
Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in
connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as
to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company,
solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on
deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated
to be $10.30 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued
and outstanding public shares, subject to certain limitations as described in the Company’s prospectus relating to its Initial Public
Offering filed with the SEC on September 17, 2021. The per-share amount to be distributed to the Public Shareholders who properly
redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed
in Note 6). There will be no redemption rights in connection with a Business Combination with respect to the Company’s warrants.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
If the Company seeks shareholder approval of the
Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution or such
other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a
shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of
Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”),
and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior
to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor
has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering
in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting,
and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company
seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules,
a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert
or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without
the Company’s prior written consent.
Each initial shareholder has agreed (a) to
waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business
Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify
the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business
Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period
(as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination
activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any
such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest
earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.
The Company will have until December 20,
2022 (or up to June 20, 2023, if applicable) from the closing of the Initial Public Offering to consummate a Business Combination
(the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period,
the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but
not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less
up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions,
if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining
Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under
Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights
or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete
a Business Combination within the Combination Period.
Each initial shareholder has agreed to waive its
rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to
complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public
Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business
Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission
(see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period,
and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption
of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for
distribution will be less than $10.30 per unit.
In order to protect the amounts held in the Trust
Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the
Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective
target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account
to below the lesser of (1) $10.30 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the
date of the liquidation of the Trust Account, if less than $10.30 per Public Share, due to reductions in the value of trust assets, in
each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed
a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities
Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible
to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have
to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s
independent registered public accounting firm), prospective target businesses or other entities with which the Company does business,
execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
Liquidity and Going Concern
As of September 30, 2022, the Company had $907,917
in its operating bank account and working capital of $936,948. In order to fund working capital deficiencies or finance transaction costs
in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or certain of the Company’s officers and
directors, may provide the Company with Working Capital Loans (as defined below) (see Note 5).
The Company may raise additional capital through
loans or additional investments from the Sponsors or its stockholders, officers, directors or third parties. The Company’s officers
and directors and the Sponsors may but are not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable
in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing, the Company believes it will have
sufficient working capital and borrowing capacity from the Sponsors or an affiliate of the Sponsors, or certain of the Company’s
officers and directors, to meet its needs through the consummation of a Business Combination.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)
2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until
December 20, 2022 (or up to June 20, 2023, if applicable) to consummate a Business Combination. It is uncertain that the Company will
be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a
mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business
Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as
a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate
after December 20, 2022 (or June 20, 2023, if applicable).
Risks and Uncertainties
Management continues to evaluate the impact of
the COVID-19 global pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the
Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable
as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.
In February 2022, the Russian Federation and Belarus
commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have
instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on
the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial
condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements as of September 30, 2022 have been prepared in accordance with accounting principles generally accepted in the United States
of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of
Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance
with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly,
they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations,
or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting
of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows
for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 28, 2022.
The interim results for the three and nine months ended September 30, 2022 is not necessarily indicative of the results to be expected
for the year ending December 31, 2022 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended
(the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
Further, Section 102(b)(1) of the JOBS Act
exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use of Estimates
The preparation of the condensed financial statements
in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial
statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current
information becomes available and accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of September 30, 2022 and December 31, 2021.
Investments Held in Trust Account
At September 30, 2022, the assets held in the
Trust Account were held in cash and U.S. Treasury securities. The Company classifies its U.S. Treasury securities as held-to-maturity
in accordance with FASB ASC Topic 320 “Investments—Debt and Equity Securities”. Held-to-maturity securities are those
securities which the Company has the ability and intent to hold until maturity. Held-to-maturity Treasury securities are recorded at amortized
costs and adjusted for the amortization or accretion of premiums or discounts. As of September 30, 2022, the investment in the Company’s
Trust Account consisted of $966 in cash and $238,427,565 in U.S. Treasury securities. All of the U.S. Treasury securities will mature
on November 17, 2022. The Company considers all investments with original maturities of more than three months but less than one year
to be short-term investments. The carrying value approximates the fair value.
At December 31, 2021, substantially all of the
assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities. All of the
Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance
sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held
in Trust Account will be included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements
of operations. The estimated fair values of investments held in Trust Account are determined using available market information.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary
shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480
“Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a
liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’
equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s
control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A ordinary
shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit
section of the Company’s balance sheets.
The Company recognizes changes in redemption value
immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each
reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional
paid in capital and accumulated deficit.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
At September 30, 2022 and December 31, 2021, the
Class A ordinary share reflected in the condensed balance sheets are reconciled in the following table:
Gross proceeds | |
$ | 230,000,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
$ | (6,003,000 | ) |
Class A ordinary shares issuance costs | |
| (13,064,007 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
$ | 25,970,956 | |
Class A ordinary shares subject to possible redemption, December 31, 2021 | |
$ | 236,903,949 | |
| |
| | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 1,524,582 | |
Class A ordinary shares subject to possible redemption, September 30, 2022 | |
$ | 238,428,531 | |
Warrant Liabilities
The Company accounts for the Public Warrants (as
defined in Note 3) and the Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) in accordance
with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded
as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value
at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair
value is recognized in the statements of operations. The quoted market price is used as the fair value as of each relevant date for valuing
the Public Warrants. The Private Placement Warrants are valued using a Black Scholes simulation.
Offering Costs
Offering costs consist of underwriting, legal,
accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering
costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis,
compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented
as non-operating expenses in the statements of operations. Offering costs associated with the Public Shares were charged to shareholders’
equity upon the completion of the Initial Public Offering. Offering costs amounted to $13,412,940, of which $13,039,746 were charged to
shareholders’ equity upon the completion of the Initial Public Offering and $373,194 were expensed to the statements of operations.
Income Taxes
The Company accounts for income taxes under ASC
740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both
the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future
tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established
when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in
a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing
authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2022 and December
31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position.
Net Income (Loss) per Ordinary Share
The Company complies with the accounting and disclosure
requirements of ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income
(loss) by the weighted average number of ordinary shares outstanding for the period. The Company has two classes of shares, which are
referred to as Class A ordinary shares and Class B ordinary shares. Income (losses) are shared pro rata between the two classes of shares.
Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding
for the respective period. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the
redemption value approximates fair value.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
The calculation of diluted net income (loss) per
share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement
since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 17,333,334
Class A ordinary shares in the aggregate. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other
contracts that could, potentially, be exercised or converted into ordinary shares and then share in the income of the Company.
The following table reflects the calculation of
basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):
| |
Three
Months Ended September 30, | | |
Nine
Months Ended | | |
For the Period from
January 29, 2021 (Inception) through | |
| |
2022 | | |
2021 | | |
September
30, 2022 | | |
September
30, 2021 | |
| |
Class
A | | |
Class
B | | |
Class
A | | |
Class
B | | |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic
and diluted net income (loss) per ordinary share | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
Allocation
of net income (loss), as adjusted | |
$ | 2,024,023 | | |
$ | 674,675 | | |
$ | (310,669 | ) | |
$ | (766,643 | ) | |
$ | 7,394,386 | | |
$ | 2,464,795 | | |
$ | (144,879 | ) | |
$ | (941,620 | ) |
Denominator: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 23,000,000 | | |
| 7,666,667 | | |
| 2,750,000 | | |
| 6,786,232 | | |
| 23,000,000 | | |
| 7,666,667 | | |
| 1,032,653 | | |
| 6,711,565 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income (loss) per ordinary share | |
$ | 0.09 | | |
$ | 0.09 | | |
$ | (0.11 | ) | |
$ | (0.11 | ) | |
$ | 0.32 | | |
$ | 0.32 | | |
$ | (0.14 | ) | |
$ | (0.14 | ) |
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying
amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
Derivative Financial Instruments
The Company evaluates its financial instrument
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic
815, “Derivatives and Hedging”. Derivative instruments are initially recorded at fair value on the grant date and revalued
at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are
classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument
could be required within 15 months of the balance sheet date.
Recent Accounting Standards
In August 2020, the Financial Accounting Standards
Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other
Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial
conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining
to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible
debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings
per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is for fiscal
years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company
adopted ASU 2020-06 effective January 29, 2021. The adoption of ASU 2020-06 did not have a material impact on the Company’s
financial statements.
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
NOTE 3. PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company
sold 23,000,000 Units, which includes a full exercise by the underwriters of their overallotment option in the amount of 3,000,000 Units,
at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public
Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per
whole share.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial
Public Offering, the Sponsor purchased an aggregate of 9,666,667 Private Placement Warrants at a price of $1.50 per Private Placement
Warrant, for an aggregate purchase price of $14,500,000, in a private placement. Each Private Placement Warrant is exercisable to purchase
one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the
Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does
not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be
used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will
expire worthless.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On February 5, 2021, the Sponsor paid $25,000
to cover certain offering and formation costs of the Company in consideration of 7,187,500 Class B ordinary shares (the “Founder
Shares”). On February 18, 2021, the Sponsor transferred 25,000 Founder Shares to each of Martha Tredgett and Greg Greeley,
in each case for consideration of $87, resulting in the Sponsor holding 7,137,500 Founder Shares. On August 31, 2021, the Company
effected a split of the outstanding Class B ordinary shares, resulting in the Sponsor holding 7,613,335 Founder Shares and Martha
Tredgett and Greg Greeley each holding 26,666 Founder Shares. All share and per-share amounts have been retroactively restated to reflect
the share split. As a result of the underwriters’ election to fully exercise their over-allotment option at the Initial Public Offering,
a total of 1,000,000 Founder Shares are no longer subject to forfeiture.
Each initial shareholder has agreed, subject to
limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion
of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the
date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public
Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
Promissory Note — Related Party
On February 5, 2021, the Company issued an unsecured
promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal
amount of $300,000. The Promissory Note was non-interest bearing and was repaid in full on October 22, 2021. As of September 30, 2022
and December 31, 2021, there was $0 outstanding under the Promissory Note.
Related Party Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a
Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company.
Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital
Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of such
Working Capital Loans may be converted into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants
would be identical to the Private Placement Warrants. As of September 30, 2022 and December 31, 2021, the Company had no outstanding borrowings
under the Working Capital Loans.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
The Company will have 15 months from the closing
of the Initial Public Offering to complete a Business Combination (or up to 21 months if it extends the period of time to consummate a
Business Combination in accordance with the terms described below). If the Company anticipates that it may not be able to consummate a
Business Combination within 15 months, it may, but is not obligated to, extend the period of time to consummate a Business Combination
two times by an additional three months each time (for a total of up to 21 months to complete a Business Combination); provided that the
Sponsor (or its designees) must deposit into the trust account funds equal to an aggregate of $2,300,000 or $0.10 per Public Share, on
or prior to the date of the applicable deadline for each of the available three month extensions, providing a total possible business
combination period of 21 months at a total payment value of $4,600,000, in exchange for a non-interest bearing, unsecured promissory note
(an “Extension Loan”). Any such Extension Loan may be converted into Private Placement Warrants, at a price of $1.50 per warrant
at the option of the lender.
Administrative Services Agreement
The Company entered into an agreement, commencing
on September 15, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an
affiliate of the Sponsor an amount not to exceed $33,333 per month for office space and secretarial and administrative services. For the
three and nine months ended September 30, 2022, the Company incurred $33,812 and $91,859 in fees related to these services, which are
included in accrued expenses in the accompanying condensed balance sheets as of September 30, 2022, respectively. For the three months
ended September 30, 2021 and for the period from January 29, 2021 (inception) through September 30, 2021, the Company did not incur any
fees for these services.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration and Shareholders Rights
Pursuant to a registration rights agreement entered
into on September 15, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon
conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants
and warrants that may be issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration
and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands,
that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect
to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights
agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until
termination of the applicable lockup period. The registration rights agreement does not contain liquidating damages or other cash settlement
provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection
with the filing of any such registration statement.
Underwriting Agreement
The underwriters are entitled to a deferred fee
of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the
Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
NOTE 7. SHAREHOLDERS’ DEFICIT
Preference Shares— The Company
is authorized to issue 5,000,000 preference shares with a par or nominal value of $0.0001 per share, with such designations, voting and
other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2022 and
December 31, 2021, there were no preference shares issued or outstanding.
Class A Ordinary Shares—
The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par or nominal value of $0.0001 per share. Holders
of Class A ordinary shares are entitled to one vote for each share. At September 30, 2022 and December 31, 2021, there were no Class A
ordinary shares issued and outstanding, excluding 23,000,000 Class A ordinary shares subject to possible redemption which are presented
as temporary equity.
Class B Ordinary Shares—
The Company is authorized to issue 53,333,345.5 Class B ordinary shares, with a par or nominal value of approximately $0.00009 per
share. Holders of the Class B ordinary shares are entitled to one vote for each share. At September 30, 2022 and December 31, 2021,
there were 7,666,667 Class B ordinary shares issued and outstanding.
Only holders of the Class B ordinary shares
will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A ordinary shares and
Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as
required by law. In connection with a Business Combination, the Company may enter into a shareholder’s agreement or other arrangements
with the shareholders of the target or other investors to provide for voting or other governance arrangements that differ from those in
effect upon completion of the Initial Public Offering.
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
The Class B ordinary shares will automatically
convert into Class A ordinary shares at the time of a Business Combination or earlier at the option of the holders thereof at a ratio
such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted basis, 25% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial
Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or
exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation
of a Business Combination, excluding Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A
ordinary shares issued, deemed issued, or to be issued, to any seller of an interest in the target to the Company in a Business Combination
and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion
of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less
than one-to-one.
NOTE 8. WARRANT LIABILITY
Warrants— As of September
30, 2022 and December 31, 2021, there are 7,666,667 outstanding Public Warrants. Public Warrants may only be exercised for a whole number
of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable 30 days
after the completion of a Business Combination. The Public Warrants will expire five years from the completion of a Business Combination
or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any
Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless
a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective
and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid
exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated to issue a Class A
ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable,
but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts
to file with the SEC a post-effective amendment to the Registration Statement or a new registration statement for the registration, under
the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its commercially
reasonable efforts to cause the same to become effective within 60 business days following the closing of a Business Combination and to
maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until
the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering
the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of
a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when
the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance
with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A ordinary shares are at the time
of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security”
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise
their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event
the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement for the registration,
under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants and, in the event the Company does
not so elect, the Company will use its commercially reasonable efforts to register or qualify the Class A ordinary shares under applicable
blue sky laws to the extent an exemption is not available.
Redemption of warrants when the price per Class A
ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except
as described with respect to the Private Placement Warrants):
| ● | in
whole and not in part; |
| ● | at
a price of $0.01 per warrant; |
| ● | upon
a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
| ● | if,
and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading
days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
If and when the warrants become redeemable by
the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale
under all applicable state securities laws.
Redemption of warrants when the price per Class A
ordinary share equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants:
| ● | in
whole and not in part; |
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
| ● | at
$0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise
their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and
the fair market value of the Class A ordinary shares; |
| ● | if,
and only if, the closing price of the Class A ordinary shares equal or exceeds $10.00 per public share (as adjusted) for any 20
trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption of the warrant
holders. |
If the Company calls the Public Warrants for redemption,
as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on
a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon
exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend
or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted
for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash
settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company
liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public
Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such
Public Warrants. Accordingly, the Public Warrants may expire worthless.
In addition, if (x) the Company issues additional
Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination
at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue
price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or
holders of the Class B ordinary shares or their respective affiliates, without taking into account any Founder Shares held by the
Sponsor, holders of the Class B ordinary shares or such affiliates, as applicable, prior to such issuance) (the “Newly Issued
Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions),
and (z) the volume-weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on
the trading day after the day on which the Company consummates its Business Combination (such price, the “Market Value”) is
below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of
the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent)
to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will
be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
As of September 30, 2022 and December 31, 2021,
there are 9,666,667 outstanding Private Placement Warrants. The Private Placement Warrants are identical to the Public Warrants underlying
the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable
upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion
of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on
a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted
transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the
Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
NOTE 9. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820 for
its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets
and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
SOAR TECHNOLOGY ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2022
(Unaudited)
The following table presents information about
the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description | |
Level | | |
September 30, 2022 | | |
December 31, 2021 | |
Assets: | |
| | |
| | |
| |
Investments held in Trust Account | |
| 1 | | |
$ | 238,428,531 | | |
$ | 236,903,949 | |
| |
| | | |
| | | |
| | |
Liabilities: | |
| | | |
| | | |
| | |
Warrant Liability – Public Warrants | |
| 1 | | |
| 306,667 | | |
| 4,370,000 | |
Warrant Liability – Private Placement Warrants | |
| 3 | | |
| 483,333 | | |
| 5,819,334 | |
The Warrants were accounted for as liabilities
in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying balance sheets. The warrant liabilities
are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statements of operations.
The quoted market price was used as the fair value
as of each relevant date for valuing the Public Warrants. The Private Placement Warrants were valued using a Black Scholes Option Pricing
Model, which is considered to be a Level 3 fair value measurement. The Black Scholes model’s primary unobservable input utilized
in determining the fair value of the Private Placement Warrants is the expected volatility that is derived from a combination of the Company’s
implied volatility of its Public Warrants and from observable public warrant pricing on comparable ‘blank-check’ companies
without an identified target.
The following table provides quantitative information
regarding Level 3 fair value measurements:
| |
September 30, 2022 | | |
December 31, 2021 | |
Stock price | |
$ | 10.30 | | |
$ | 10.11 | |
Exercise price | |
$ | 11.50 | | |
$ | 11.50 | |
Expected term (in years) | |
| 5.21 | | |
| 5.71 | |
Volatility | |
| — | % | |
| 8.6 | % |
Risk-free rate | |
| 3.97 | % | |
| 1.32 | % |
Dividend yield | |
| — | % | |
| — | % |
The following table presents the changes in the
fair value of Level 3 warrant liabilities:
| |
Private Placement | | |
Public | | |
Warrant Liabilities | |
Fair value as of December 31, 2021 | |
$ | 5,819,334 | | |
$ | — | | |
$ | 5,819,334 | |
Change in valuation inputs or other assumptions | |
| (2,146,001 | ) | |
| — | | |
| (2,146,001 | ) |
Fair value as of March 31, 2022 | |
$ | 3,673,333 | | |
$ | — | | |
$ | 3,673,333 | |
Change in valuation inputs or other assumptions | |
| (1,933,333 | ) | |
| — | | |
| (1,933,333 | ) |
Fair value as of June 30, 2022 | |
$ | 1,740,000 | | |
$ | — | | |
$ | 1,740,000 | |
Change in valuation inputs or other assumptions | |
| (1,256,667 | ) | |
| — | | |
| (1,256,667 | ) |
Fair value as of September 30, 2022 | |
$ | 483,333 | | |
$ | — | | |
$ | 483,333 | |
Transfers to/from Levels 1, 2 and 3 are recognized
at the end of the reporting period in which a change in valuation technique or methodology occurs. No transfers occurred during the three
and nine months ended September 30, 2022.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review,
the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.